Evidence map›Paper›PMID 28326250›Full record

ArticleJournal of kidney cancer and VHL2014

Tubulocystic Renal Cell Carcinoma: A Rare Renal Tumor.

Jasneet Singh Bhullar, Sandiya Bindroo, Neha Varshney, Vijay Mittal

Open access · diamondAbstract read
In one paragraph

Article in Journal of kidney cancer and VHL, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jasneet Singh BhullarDepartment of Surgery, Providence Hospital & Medical Centers, Southfield, MI, USA; Department of Pathology, University of Toledo, Toledo, OH, USA.
Sandiya BindrooDepartment of Surgery, Providence Hospital & Medical Centers, Southfield, MI, USA; Department of Pathology, University of Toledo, Toledo, OH, USA.
Neha VarshneyDepartment of Surgery, Providence Hospital & Medical Centers, Southfield, MI, USA; Department of Pathology, University of Toledo, Toledo, OH, USA.
Vijay MittalDepartment of Surgery, Providence Hospital & Medical Centers, Southfield, MI, USA; Department of Pathology, University of Toledo, Toledo, OH, USA.
Providence Hospital · USUniversity of Toledo · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulocystic renal cell carcinoma of the kidney is a rare entity with less than one hundred cases reported so far. It was previously considered to have some similarities to various other renal cancers although this tumor has distinct macroscopic, microscopic and immuno-histochemical features. It is now a well-established entity in renal neoplastic pathology and has been recognized as a distinct entity in the 2012 Vancouver classification of renal tumors. This review aims to give an overview of tubulocystic renal cell carcinoma after extensive literature search using PubMed and CrossRef.

Identifiers

PMID28326250
PMCPMC5345545
OpenAlexW2011365044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.